Clinical Trial Update: FSRT Combines With Bevacizumab for Multiple Brain Metastases in Lung Adenocarcinoma [Phase 3]

View source ↗

Summary

A Phase 3 clinical trial is evaluating the combination of fractionated stereotactic radiotherapy (FSRT) with bevacizumab for patients with multiple brain metast…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Brain Metastases
• Lung Adenocarcinoma

Drugs mentioned

• Bevacizumab (bevacizumab)

Snippet

Sponsor: Sun Yat-Sen University Cancer Center | Conditions: Multiple Brain Metastases in Lung Adenocarcinoma | Phase 3 | Status: RECRUITING